The HLA class II allele DQB1*0309 is associated with dilated cardiomyopathy

Gene

Volumn 531, Issue 2, 2013, Pages 180-183

  Pankuweit, Sabine ^a   Ruppert, Volker ^a   Jónsdóttir, Thurídur ^a   Müller, Hans Helge ^b   Meyer, Thomas ^c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Allele distribution; Dilated cardiomyopathy; HLA; MHC; Polymorphisms

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; ETHNIC GROUP; FEMALE; GENOTYPE; HEART; HEART MUSCLE BIOPSY; HUMAN; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PRIORITY JOURNAL; VIRUS GENOME;

ALLELE DISTRIBUTION; DCM; DEOXYRIBONUCLEIC ACID; DILATED CARDIOMYOPATHY; DNA; EF; EJECTION FRACTION; HLA; HUMAN LEUKOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY COMPLEX; MHC; POLYMORPHISMS; SEQUENCE-SPECIFIC PRIMER-POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; SSP-PCR;

ADULT; AGED; ALLELES; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ BETA-CHAINS; HUMANS; MALE; MIDDLE AGED;

EID: 84885422876     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.09.022     Document Type: Article

References (35)

1. Anderson J.L., Carlquist J.F., Lutz J.R., DeWitt C.W., Hammond E.H. HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors. Am. J. Cardiol. 1984, 53:1326-1330.
2. Arbustini E., Gavazzi A., Pozzi R., et al. The morphologic spectrum of dilated cardiomyopathy and its relation to immune-response genes. Am. J. Cardiol. 1989, 64:991-995.
3. Caforio A.L. Role of autoimmunity in dilated cardiomyopathy. Br. Heart J. 1994, 72:S30-S34.
4. Caforio A.L., Stewart L., Bonifacio E., et al. Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity?. J. Autoimmun. 1990, 3:187-200.
5. Caforio A.L., Mahon N.J., Tona F., McKenna W.J. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur. J. Heart Fail. 2002, 4:411-417.
6. Carlquist J.F., Menlove R.L., Murray M.B., O'Connell J.B., Anderson J.L. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies. Circulation 1991, 83:515-522.
7. Colorado I.A., Acquatella H., Catalioti F., Fernandez M.T., Layrisse Z. HLA class II DRB1, DQB1, DPB1 polymorphism and cardiomyopathy due to Trypanosoma cruzi chronic infection. Hum. Immunol. 2000, 61:320-325.
8. García Borrás S., Diez C., Cotorruelo C., et al. HLA class II DRB1 polymorphism in Argentinians undergoing chronic Trypanosoma cruzi infection. Ann. Clin. Biochem. 2006, 43:214-216.
9. Harcombe A.A., Sharples L., Large S.R., Wallwork J., Weissberg P.L., Joysey V. HLA antigen frequencies in end-stage idiopathic and ischaemic cardiomyopathy. Int. J. Cardiol. 1999, 68:31-37.
10. Hiroi S., Harada H., Nishi H., Satoh M., Nagai R., Kimura A. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem. Biophys. Res. Commun. 1999, 261:332-339.
11. Jin B., Luo X.P., Ni H.C., Shen W., Shi H.M., Li Y. A meta-analysis of HLA-DR polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy. Mol. Biol. Rep. 2012, 39:221-226.
12. Kimura A. Contribution of genetic factors to the pathogenesis of dilated cardiomyopathy: the cause of dilated cardiomyopathy: genetic or acquired? (genetic-side). Circ. J. 2011, 75:1756-1765.
13. Komajda M., et al. Antigènes HLA A-B et DR dans les myocardiopathies dilatées. Arch. Mal. Coeur Vaiss. 1987, 80:1233-1237.
14. Li X., Luo R., Jiang R., Chen R., Hua W. Human leukocyte antigen-DQ beta 1 chain (DQB1) gene polymorphisms are associated with dilated cardiomyopathy: a systematic review and meta-analysis. Heart Lung 2012, 41:360-367.
15. Limas C.J. Autoimmunity in dilated cardiomyopathy and the major histocompatibility complex. Int. J. Cardiol. 1996, 54:113-116.
16. Limas C.J., Limas C. HLA antigens in idiopathic dilated cardiomyopathy. Br. Heart J. 1989, 62:379-383.
17. Limas C.J., Limas C. HLA-DR antigen linkage of anti-β receptor antibodies in idiopathic dilated and ischaemic cardiomyopathy. Br. Heart J. 1992, 67:402-425.
18. Limas C.J., Limas C., Goldenberg I.F., Blair R. Possible involvement of the HLA-DQB1 gene in susceptibility and resistance to human dilated cardiomyopathy. Am. Heart J. 1995, 129:1141-1144.
19. Liu W., Li W., Sun N. Association of HLA-DQ with idiopathic dilated cardiomyopathy in a northern Chinese Han population. Cell. Mol. Immunol. 2004, 1:311-314.
20. Liu W., Li W.M., Sun N.L. HLA-DQA1, -DQB1 polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy in Hans of northern China. Ann. Hum. Genet. 2005, 69:382-388.
21. Liu W., Li W.M., Yang S.S., et al. Association of HLA class II DRB1, DPA1 and DPB1 polymorphism with genetic susceptibility to idiopathic dilated cardiomyopathy in Chinese Han nationality. Autoimmunity 2006, 39:461-467.
22. Maharaj B., Hammond M.G. HLA-A, B, DR, and DQ antigens in black patients with idiopathic dilated cardiomyopathy. Am. J. Cardiol. 1990, 65:1402-1403.
23. Mahjoub S., Mehri S., Ghazouani E., et al. HLA class II polymorphisms in Tunisian patients with dilated cardiomyopathy. Tissue Antigens 2010, 75:679-683.
24. Martinetti M., Dugoujon J.M., Caforio A.L., et al. HLA and immunoglobulin polymorphisms in idiopathic dilated cardiomyopathy. Hum. Immunol. 1992, 35:193-199.
25. McKenna C.J., Codd M.B., McCann H.A., Sugrue D.D. Idiopathic dilated cardiomyopathy: Familial prevalence and HLA distribution. Heart 1997, 77:549-552.
26. Meder B., Rühle F., Weis T., et al. A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur. Heart J. 2013, (in press).
27. Mestroni L., Maisch B., McKenna W.J., et al. Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur. Heart J. 1999, 20:93-102.
28. Nishi H., Kimura A., Fukuta S., et al. Genetic analysis of dilated cardiomyopathy. HLA and immunoglobulin genes may confer susceptibility. Jpn. Circ. J. 1992, 56:1054-1061.
29. Nishi H., Koga Y., Koyanagi T., et al. DNA typing of HLA class II genes in Japanese patients with dilated cardiomyopathy. J. Mol. Cell. Cardiol. 1995, 27:2385-2392.
30. Osa A., Almenar L., Palencia M., Puig N., Chirivella M., Montoro J. Antigens of the major histocompatibility system in ischemic heart disease and idiopathic dilated cardiomyopathy. Clin. Cardiol. 1999, 22:292-296.
31. Portig I., Sandmoeller A., Kreilinger S., Maisch B. HLA-DQB1* polymorphism and associations with dilated cardiomyopathy, inflammatory dilated cardiomyopathy and myocarditis. Autoimmunity 2009, 42:33-40.
32. Praditpornsilpa K., Kupatawintu P., Mongkonsritagoon W., et al. The association of anti-r-HuEpo-associated pure red cell aplasia with HLA-DRB1*09-DQB1*0309. Nephrol. Dial. Transplant. 2009, 24:1545-1549.
33. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996, 93:841-842.
34. Staab J., Ruppert V., Pankuweit S., Meyer T. Polymorphisms in genes encoding nonsarcomeric proteins and their role in the pathogenesis of dilated cardiomyopathy. Herz 2012, 37:836-841.
35. Wang Q., Liao Y., Gong F., Mao H., Zhang J. HLA-DRB1 gene polymorphism in patients with dilated cardiomyopathy. J. Tongji Med. Univ. 2000, 20:141-142.